<i>CALR</i> frameshift mutation detection in myeloproliferative neoplasms by microfluidic chip analysis
We determined that the microfluidic chip assay to detect CALR exon 9 mutations was acceptable for clinical use. Compared with the conventional method, the microfluidic analysis assay benefits from a streamlined workflow, faster turnaround, and a smaller instrument footprint.
Authors
- Kristi Pepper
- Heather Hendrickson (ORCID: https://orcid.org/0000-0003-3471-4397)
- Randall J. Olsen (ORCID: https://orcid.org/0000-0003-4828-7322)
- Jessica S. Thomas (ORCID: https://orcid.org/0000-0003-0053-3467)
- Keith Newton
- Michael P Greenwood (ORCID: https://orcid.org/0009-0000-1783-443X)
Institutions
- Methodist Hospital (US)
Publication Details
- Journal
- Laboratory Medicine
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1093/labmed/lmae096
- Citations
- 1
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- Houston Methodist Hospital
- Houston Methodist Research Institute